Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-312-3 | CAS number: 53880-05-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2002-07-15 - 2003-03-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- - modified LLNA (IMDS): Measurement of cell counts instead of radioactive labeling. In addition, measurements of ear swelling and ear weights were done to discriminate the irritating potential from the sensitizing potential of the test substance.
- Principles of method if other than guideline:
- Modified LLNA (IMDS; Integrated Model for the Differentiation of Skin Reactions). Modifications are authorized in the OECD TG 429 and the Note of
Guidance SWP/ 2145/00 of the CPMP (2001). Information on validation of IMDS and scientific justification is given in: Vohr HW et al., Arch. Toxicol.,
73, 501-509 (2000); Ehling G et al., Toxicology 212, 60-68 and 69-79 (2005). - GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers
- EC Number:
- 500-125-5
- EC Name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers
- Cas Number:
- 53880-05-0
- Molecular formula:
- residual C12H18N2O2, otherwise C36H54N6O6 (trimer) and higher species
- IUPAC Name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer
- Reference substance name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, isocyanurate type
- EC Number:
- 931-312-3
- Cas Number:
- 53880-05-0
- Molecular formula:
- residual C12H18N2O2, otherwise C36H54N6O6 (trimer) and higher species
- IUPAC Name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, isocyanurate type
- Details on test material:
- Desmodur Z 4470 MPA/X; Batch No. 2.4/1-6; isophorone diisocyanate (IPDI) homopolymer of Bayer AG, purity not reported, 70 % solution in
1-Methoxypropylacetate-2/Xylol (1:1)
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan-Winkelmann GmbH, Borchen, Germany
- Strain: Hsd Win: NMRI
- Age at study initiation: no data
- Weight at study initiation: no data
- Housing: individual
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 2
- Humidity (%): 40 - 70
- Air changes (per hr): about 10
- Photoperiod (hrs dark/ hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Remarks:
- The stability of the test item in the vehicle was analytically verified for up to 2 hours.
- Concentration:
- 0, 3, 10, 30%
- No. of animals per dose:
- 6
- Details on study design:
- TREATMENT PREPARATION AND ADMINISTRATION:
The test item was formulated immediately before each administration in dimethylformamide. The test item in the formulation was applied
epicutaneously onto the dorsal part of both ears of the animals. This treatment was repeated on three consecutive days (d0, d1 and d2). The volume
administered was 25µl/ear.
The animals were anaesthetized by inhalation of carbon dioxide and sacrificed one day after the last application (d3). The appropriate organs were
then removed. Lymphatic organs (the auricular lymph nodes) were transferred into physiiological saline (PBS).
Investigations:
- weight of lymph nodes
- cell counts in lymph nodes
- stimulation index is calculated by dividing the absolute number of weight or cell counts of the substance treated lymph nodes by the vehicle treated ones.
- ear swelling
- ear weight - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- When it was statistically reasonable, the values from treated groups were compared with those from the control group(s; vehicle) by a the Mann-
Whitney (Ann. Math. Stat. 18, 1947, 50-60) or the Wilcoxon (Biometrics 1, 1945, 80-83) significance test. at significance levels of 5%. Outlying values
in the LN weights were eliminated at a probability level of 99% by Nalimov's method (Statistik für naturwissenschaftliche Berufe, 1982, 88-89). In
addition, for the LLNA/IMDS the smallest significant differentes in the means were calculated by Scheffe's method (Biometrica 40, 1953, 87-104),
which according to Sachs (Angewandte Statistik 6th and 10th edition, Springer Verlag, Berlin, 1978/2002 ) can be used for both equal and unequal
sample sizes.
Results and discussion
- Positive control results:
- Performed in 2002. The "positive level" which is 1.3 for cell counts has been statistically significant exceeded in the highest dose group (30%).
(Cell index/concentration: 0.88 / 3%; 1.13/ 10%; 1.77/ 30%)
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- The "positive level" which is 1.3 for cell counts has been exceeded in all dose groups, but the increase was only statistifically significant in the lowest dose group (3%). Cell count index = 2.29 (3%) / 1.43 (10%) / 1.68 (30%); test substance: 70 % solution in 1-Methoxypropylacetate-2/Xylol (1:1)
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: modified LLNA; measurement of cell counts instead of radioactive labeling
Any other information on results incl. tables
Compared to vehicle-treated animals, there was no increase regarding weight of the draining lymph nodes in all dose groups (weight index = 1.16 (3%) / 1.14 (10%) / 1.26 (30%)). The "positive level" of ear swelling which is 2 x 10exp-2 mm increase has not been reached or exceeded in any dose group. A slight significant increase compared to vehicle treated animals regarding ear swelling was detected in the highest dose group. No increase in the ear weights were observed in any dose group. (ear swelling - day 0 = 18.67 (0%) / 18.00 (3%) / 18.75 (10%) / 18.17 (30%); - day 3 = 18.17 (0%) / 18.25 (3%) / 18.92 (10%) / 19.50 (30%); ear weight - day 3 = 11.53 (0%) / 11.33 (3%) / 11.58 (10%) / 11.68 (30%))
Applicant's summary and conclusion
- Conclusions:
- The results show that the test item (Desmodur Z 4470 MPA/X) has a slight irritating and a sensitizing potential in mice after dermal application.
- Executive summary:
A modified LLNA (IMDS; OECD TG 429) was performed on 6 female NMRI mice per dose group using test item concentrations of 0% (vehicle control), 3%, 10% and 30%.
There was no increase compared to control animals regarding weight of the draining lymph nodes in all dose groups. Compared to vehicle treated animals the cell counts exceeded the "positive levels" defined for this assay in all dose groups, but only in the lowest group the increase was statistically significant. A slight significant increase compared to vehicle treated animals regarding ear swelling was detected in the highest dose group. No increase was determined for the ear weights in any dose group.
Under the conditions of this study the test item IPDI homopolymer has a slight irritating and a sensitizing potential in mice after dermal application.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.